Abstract:BACKGROUND AND OBJECTIVEMultiple drug resistance (MDR) to chemotherapeutic agents often leads to a failure to respond to chemotherapy. We utilized an in vitro chemosensitivity test to identify sensitive and effective chemotherapeutic drugs and further elucidated the correlation between the in vivo chemosensitivity and clinical outcomes.METHODSHere, we evaluated the in vitro chemosensitivity and MDR of 120 lung cancer patients to eight singledrug chemotherapies and of 291 lung cancer patients to seven chemotherapy regimens using an ATP-based tumor chemosensitivity assay (ATP-TCA). Additionally, the chemosensitivity profiles of lung adenocarcinoma patients (284 cases) and lung squamous cell carcinoma patients (90 cases) to these single-drug and chemotherapy regimens were compared. Furthermore, the correlations between the chemosensitivity and clinical outcomes were investigated in 16 stage III squamous cell carcinoma patients.RESULTS AND CONCLUSIONPTX (51.7%), TXT (43.3%), GEM (12.5%), PTX+DDP (62.5%), TXT+L-OHP (54.3%) and VP-16+DDP (16.2%) had the highest in vitro chemosensitivity rates. Approximately 31.7% of patients developed resistance to all eight single-drug chemotherapies, and 25.8% of patients displayed resistance to all seven chemotherapy regimens. In addition, lung squamous cell carcinoma was significantly more sensitive to GEM and MTA+DDP than lung adenocarcinoma (P<0.05). Further analysis showed that patients with higher drug sensitivity tended to have longer disease-free survival (18 months vs. 8.5 months) than patients displaying drug resistance (P<0.05). These results suggest that the implementation of in vitro drug susceptibility testing before chemotherapy can effectively prevent the occurrence of primary drug resistance and inappropriate drug treatment.

Research on the Application of Centrifugaation of Different Grades in Drugs' Sensitivity Expriment of Cancer and Its Clinic Relativity

Experimental Study on the Anti - Cancer Drugs' Sensitivity in the Colormetric Assay of Cancer Cells with MTT and Its Effective Factors

Analysis of Cytotoxic Effects of Chemotherapeutic Agents for Gastrointestinal Cancer with Cell-based Impedance Biosensor

Analysis on the Detected Chemotherapeutic Drug Sensitivity Results of Gastric Cancer Cells by Using MTT Method

Clinical Study on Sensitivity of Oral and Maxillofacial Cancers with Chemotherapy

The effect of fibronectin and arginine-glycine-aspartic-serine tetrepeptide on chemotherapy sensitivity of liver carcinoma cell lines

Study of chemosensitivity for human breast cancer cells cultivated in primary generation in vitro

Study on the sensitivity of primary tumor cells of patients with cervical cancer to chemotherapeutic combinations

Analysis of Drug Sensitivity and Its Guidance in Clinic in 61 Cases of Breast Cancer Cell

Sensitivity of Different Chemotherapy Drugs on the Liver Cancer Ceil Lines under Environment of Intervention Therapy

Study on susceptibility of eight common chemotherapy drug combinations in human cervical carcinoma cell in vitro

Study on the Sensitivity of Primary Glioma Cell to Chemotherapeutic Agents in Vitro

Individualized cancer chemotherapy integrating drug sensitivity tests, pathological profile analysis and computational coordination – An effective strategy to improve clinical treatment

Evaluation of the in Vitro Chemosensitivity and Correlation with Clinical Outcomes in Lung Cancer Using the ATP-TCA.

Comparison of Cytotoxicity Evaluation of Anticancer Drugs between Real-Time Cell Analysis and CCK-8 Method

Detection of Chemosensitivity of Cervical Carcinoma in Vitro by MTT Assay and Its Clinical Significance

Heterogeneity in Primary Tumors and Corresponding Metastases: Could It Provide Us with Any Hints to Personalize Cancer Therapy?

Study on the chemosensitivity test with TECIA in vitro for the choice of individualized chemotherapy of lung cancer

APOPTOSIS AND DRUG SENSITITY TEST OF LUNG CANCER CELL

Anticancer Drug Sensitivity Test of Malignant Plcural and Ascitic Fluid with MTT Colorimetric Method

Chemosensitivity in vitro of 25 anti-cancer drugs to primary cultured human breast cancer cells